COVID-19 Vaccine Provider Weekly Updates

Stay Safe MN logo

COVID-19 Vaccine Provider Weekly Updates

View this as a webpage

May 5, 2023


COVID-19 vaccination guidance for people moderately or severely immunocompromised

On May 1, the Centers for Disease Control and Prevention (CDC) updated their Interim Clinical Considerations for COVID-19 vaccination guidance for people who are moderately or severely immunocompromised. The updates for this population include: 

  • At the time of initial vaccination, people ages 6 months and older are recommended to receive 3 bivalent mRNA doses. 
  • People ages 6 months and older who previously received only monovalent doses are recommended to receive 1 or 2 bivalent vaccine doses, depending on age and vaccine product. 
  • People who previously received a bivalent vaccine dose(s) have the option to receive 1 or more additional bivalent mRNA doses. 
  • People ages 6 months and older have the option to receive 1 additional dose of bivalent vaccine at least 2 months following the last recommended bivalent dose. Additional doses may be administered, informed by the clinical judgement of a health care provider and personal preference and circumstances. Any additional doses should be administered at least 2 months after the last COVID-19 vaccine dose. 

MDH resources, including COVID-19 vaccination protocols, have been updated to reflect these changes on COVID-19 Vaccine Providers. 

MIIC spring 2023 webinar series

The four-part MIIC webinar series began on April 19. The remaining sessions will be held on Wednesdays from 11 a.m. to noon. MIIC staff will cover several aspects of MIIC and include time for questions. To view the recordings for webinars one and two visit MIIC User Guidance and Training Resources. 

If you have any questions or need access to the registration links email the MIIC Help Desk at 

Up to date with current recommendations

CDC continues to recommend that everyone ages 6 months and older stay up to date with all COVID-19 vaccines, including a bivalent vaccine when eligible. People ages 6 years and older are up to date when they get 1 bivalent Pfizer or Moderna vaccine. Children 6 months to 5 years may require multiple doses to be considered up to date. People who are unable or choose not to get an mRNA vaccine, are up to date when they receive all Novavax COVID-19 vaccine doses approved for their age. For more details, refer to the Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States and Stay Up to Date with COVID-19 Vaccines. 

Updates on V-safe

On May 19, V-safe will close for new enrollments and those enrolled will be unable to add new COVID-19 vaccine doses to their account. Health check-ins for any doses added before this date will continue until June 30. Participants will continue to have access to their account to review previous entries and to complete remaining health check-ins until June 30. Refer to V-safe After Vaccination Health Checker for more information. 

CDC will continue to monitor COVID-19 vaccine safety through its other vaccine safety monitoring systems, including Vaccine Adverse Event Reporting system (VAERS). 

Janssen (Johnson & Johnson) vaccine expiration

We would like to remind providers that all remaining doses of Janssen COVID-19 vaccine in the U.S. will expire tomorrow, May 6. Please ensure all remaining vials are disposed of appropriately and any resulting wastage is recorded in MIIC. 

Find previous bulletins at COVID-19 Vaccine Provider Updates.